Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Samid

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Biochemical Pharmacology|October 25, 1996
Transcriptional upregulation of gamma-globin by phenylbutyrate and analogous aromatic fatty acidsW R Hudgins, E Fibach, S Safaya, et al.
Journal of Neurosurgery|October 1, 1995
Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetateG Stockhammer, G T Manley, R Johnson, et al.
Cellular Immunology|July 1, 1994
Upregulation of tumor necrosis factor-alpha production by retrovirally transduced human tumor-infiltrating lymphocytes using trans-retinoic acidJ Treisman, P Hwu, J R Yannelli, et al.
Biochemical Pharmacology|August 23, 1996
Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogsT Pineau, W R Hudgins, L Liu, et al.
Cancer Research|April 1, 1994
Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidineJ Weber, M Salgaller, D Samid, et al.
Leukemia|August 18, 1999
Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysisJ A DiGiuseppe, L J Weng, K H Yu, et al.
Journal of Clinical Pharmacology|April 1, 1995
Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamineS C Piscitelli, A Thibault, W D Figg, et al.
Cancer Research|February 15, 1994
Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuriaD Samid, Z Ram, W R Hudgins, et al.
Tumori|June 10, 1998
A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancerA Thibault, W D Figg, R C Bergan, et al.
Anti-Cancer Drugs|June 1, 1994
In vitro antitumor effect of hydroxyurea on hormone-refractory prostate cancer cells and its potentiation by phenylbutyrateW D Figg, R G Walls, M R Cooper, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Biochemical Pharmacology|October 25, 1996
Transcriptional upregulation of gamma-globin by phenylbutyrate and analogous aromatic fatty acidsW R Hudgins, E Fibach, S Safaya, et al.
Journal of Neurosurgery|October 1, 1995
Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetateG Stockhammer, G T Manley, R Johnson, et al.
Cellular Immunology|July 1, 1994
Upregulation of tumor necrosis factor-alpha production by retrovirally transduced human tumor-infiltrating lymphocytes using trans-retinoic acidJ Treisman, P Hwu, J R Yannelli, et al.
Biochemical Pharmacology|August 23, 1996
Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogsT Pineau, W R Hudgins, L Liu, et al.
Cancer Research|April 1, 1994
Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidineJ Weber, M Salgaller, D Samid, et al.
Leukemia|August 18, 1999
Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysisJ A DiGiuseppe, L J Weng, K H Yu, et al.
Journal of Clinical Pharmacology|April 1, 1995
Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamineS C Piscitelli, A Thibault, W D Figg, et al.
Cancer Research|February 15, 1994
Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuriaD Samid, Z Ram, W R Hudgins, et al.
Tumori|June 10, 1998
A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancerA Thibault, W D Figg, R C Bergan, et al.
Anti-Cancer Drugs|June 1, 1994
In vitro antitumor effect of hydroxyurea on hormone-refractory prostate cancer cells and its potentiation by phenylbutyrateW D Figg, R G Walls, M R Cooper, et al.
Pageof 7